Rep. Gilbert Ray Cisneros, Jr. Sells Shares of Corteva, Inc. (NYSE:CTVA)

Representative Gilbert Ray Cisneros, Jr. (Democratic-California) recently sold shares of Corteva, Inc. (NYSE:CTVA). In a filing disclosed on November 10th, the Representative disclosed that they had sold between $1,001 and $15,000 in Corteva stock on October 14th. The trade occurred in the Representative’s “150 MAIN STREET TRUST > BANK OF AMERICA” account.

Representative Gilbert Ray Cisneros, Jr. also recently made the following trade(s):

  • Purchased $1,001 – $15,000 in shares of BridgeBio Pharma (NASDAQ:BBIO) on 11/2/2026.
  • Purchased $1,001 – $15,000 in shares of argenex (NASDAQ:ARGX) on 10/27/2026.
  • Sold $1,001 – $15,000 in shares of Illumina (NASDAQ:ILMN) on 10/27/2026.
  • Sold $1,001 – $15,000 in shares of Revvity (NYSE:RVTY) on 10/27/2026.
  • Sold $15,001 – $50,000 in shares of PTC (NASDAQ:PTC) on 10/27/2026.
  • Purchased $1,001 – $15,000 in shares of BridgeBio Pharma (NASDAQ:BBIO) on 10/27/2026.
  • Purchased $1,001 – $15,000 in shares of MACOM Technology Solutions (NASDAQ:MTSI) on 10/27/2026.
  • Sold $1,001 – $15,000 in shares of Micron Solutions (OTCMKTS:MICR) on 10/21/2026.
  • Sold $1,001 – $15,000 in shares of Ciena (NYSE:CIEN) on 10/21/2026.
  • Purchased $1,001 – $15,000 in shares of ServiceNow (NYSE:NOW) on 10/21/2026.

Corteva Price Performance

NYSE:CTVA traded down $2.88 during mid-day trading on Thursday, reaching $9.26. The stock had a trading volume of 64,905,908 shares, compared to its average volume of 20,070,060. The firm has a 50 day moving average price of $38.81 and a two-hundred day moving average price of $69.88. The stock has a market capitalization of $6.18 billion, a P/E ratio of 3.20, a P/E/G ratio of 1.69 and a beta of 0.58. Corteva, Inc. has a one year low of $9.14 and a one year high of $90.97. The company has a debt-to-equity ratio of 0.07, a quick ratio of 1.10 and a current ratio of 1.52.

Corteva (NYSE:CTVA – Get Free Report) last announced its quarterly earnings data on Thursday, November 12th. The company reported $0.06 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.02 by $0.04. Corteva had a net margin of 5.66% and a return on equity of 10.18%. The company had revenue of $2.46 billion during the quarter, compared to analysts’ expectations of $1.77 billion. During the same quarter in the prior year, the company earned ($0.23) EPS. The firm’s revenue was down 8.7% on a year-over-year basis. As a group, analysts expect that Corteva, Inc. will post 1.05 earnings per share for the current year.

Corteva Cuts Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 15th. Investors of record on Tuesday, December 1st will be issued a dividend of $0.05 per share. The ex-dividend date of this dividend is Tuesday, December 1st. This represents a $0.20 dividend on an annualized basis and a dividend yield of 2.2%. This is a negative change from Corteva’s previous quarterly dividend of $0.18. Corteva’s payout ratio is 47.68%.

Institutional Trading of Corteva

Several large investors have recently bought and sold shares of the company. BlackRock Inc. bought a new stake in Corteva during the second quarter worth about $4,560,180,000. Wellington Management Group LLP lifted its holdings in shares of Corteva by 941.7% during the second quarter. Wellington Management Group LLP now owns 7,612,704 shares of the company’s stock valued at $644,720,000 after purchasing an additional 6,881,875 shares during the last quarter. Jupiter Topco LLC bought a new stake in shares of Corteva in the 2nd quarter worth approximately $544,246,000. Bank of America Corp DE bought a new position in Corteva during the 2nd quarter valued at approximately $484,927,000. Finally, Legal & General Group Plc purchased a new position in Corteva during the second quarter valued at $482,836,000. 81.54% of the stock is owned by institutional investors.

Trending Headlines about Corteva

Here are a few of the latest headlines about CTVA:

  • Positive Sentiment: Corteva said new-product sales growth and operational execution helped cushion market headwinds. One report also showed adjusted Q3 EPS of $0.06, above the $0.02 consensus estimate, though coverage described the overall quarter as weak and results varied by measure. Corteva Q3 results and outlook
  • Negative Sentiment: Corteva lowered its 2026 EPS guidance to $0.76–$0.80, below the roughly $1.07 analyst consensus. The company cited weaker-than-expected conditions in Brazil, where the CEO warned the slump could continue. Reuters report on Brazil weakness and forecast cut
  • Negative Sentiment: Brazilian weakness, competitive pricing and lower volumes weighed on sales and earnings. Revenue was down 8.7% year over year, while pricing pressure in North and Latin America added to concerns about the company’s near-term performance. Zacks report on Q3 results

Wall Street Analyst Weigh In

Several analysts have weighed in on the company. BMO Capital Markets set a $15.00 price objective on Corteva in a research report on Friday, October 2nd. The Goldman Sachs Group reissued a “buy” rating and set a $20.00 price objective on shares of Corteva in a research note on Thursday, October 8th. UBS Group cut their target price on shares of Corteva to $15.00 and set a “neutral” rating on the stock in a report on Monday, October 12th. Citigroup lifted their target price on shares of Corteva from $86.00 to $91.00 and gave the stock a “neutral” rating in a research note on Thursday, September 17th. Finally, Deutsche Bank reiterated a “buy” rating and set a $101.00 price target on shares of Corteva in a report on Monday, August 3rd. Sixteen research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $56.91.

Read Our Latest Analysis on Corteva

About Representative Cisneros

Gil Cisneros (Democratic Party) is a member of the U.S. House, representing California’s 31st Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027.

Cisneros (Democratic Party) is running for re-election to the U.S. House to represent California’s 31st Congressional District. He declared candidacy for the 2026 election.

Gil Cisneros served in the U.S. Navy as a supply officer from 1994 to 2004. Cisneros earned a bachelor’s degree in political science from George Washington University in 1994, a master’s in business administration from Regis University in 2002, and a master’s degree in urban education policy from Brown University in 2015. His career experience includes working as a logistics manager for Frito-Lay. In 2010, Cisneros won the lottery and became involved in activism and philanthropy, founding a scholarship program for local high school students. In 2021, President Joe Biden (D) appointed Cisneros as under secretary of defense for personnel and readiness.

Corteva Company Profile

(Get Free Report)

Corteva, Inc. is an agricultural science company that develops and supplies products and services for farmers. Its business focuses on seeds and crop protection, including technologies intended to help improve crop performance and manage weeds, insects, and plant diseases. Its seed portfolio includes corn, soybean, and other crop varieties, sold under brands such as Pioneer and Brevant. Corteva’s crop protection offerings include herbicides, insecticides, fungicides, and biological products, alongside digital tools and services that support farm decision-making.

Further Reading

Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.